Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rapid screening for resistance to ganciclovir and foscarnet of primary isolates of human cytomegalovirus from culture-positive blood samples.

Literature DB >> 7751388

Rapid screening for resistance to ganciclovir and foscarnet of primary isolates of human cytomegalovirus from culture-positive blood samples.

G Gerna¹, A Sarasini, E Percivalle, M Zavattoni, F Baldanti, M G Revello.

Abstract

A rapid screening assay for the detection of resistance to ganciclovir and foscarnet of primary isolates of human cytomegalovirus from culture-positive blood samples was developed by using single doses of both drugs and an immediate-early antigen plaque reduction assay. Results of the rapid assay with peripheral blood leukocytes as the viral inoculum were compared with those of a conventional assay with cell-free virus from the relevant viral isolates. Both assays gave overlapping results. The rapid assay offers the following major advantages: (i) it provides results within 4 to 6 days, (ii) it can be performed with peripheral blood leukocytes, and (iii) it reliably detects drug-resistant human cytomegalovirus strains.

Entities: Chemical Species

Mesh：

Substances：

Year: 1995 PMID： 7751388 PMCID： PMC228025 DOI： 10.1128/jcm.33.3.738-741.1995

Source DB: PubMed Journal: J Clin Microbiol ISSN： 0095-1137 Impact factor: 5.948

14 in total

1. Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patient.

Authors: K K Knox; W R Drobyski; D R Carrigan
Journal: Lancet Date: 1991-05-25 Impact factor: 79.321

2. Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients.

Authors: A Erice; S Chou; K K Biron; S C Stanat; H H Balfour; M C Jordan
Journal: N Engl J Med Date: 1989-02-02 Impact factor: 91.245

3. Metabolic activation of the nucleoside analog 9-[( 2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human diploid fibroblasts infected with human cytomegalovirus.

Authors: K K Biron; S C Stanat; J B Sorrell; J A Fyfe; P M Keller; C U Lambe; D J Nelson
Journal: Proc Natl Acad Sci U S A Date: 1985-04 Impact factor: 11.205

4. In situ ELISA for the evaluation of antiviral compounds effective against human cytomegalovirus.

Authors: W A Tatarowicz; N S Lurain; K D Thompson
Journal: J Virol Methods Date: 1991 Nov-Dec Impact factor: 2.014

5. Cytomegalovirus resistant to foscarnet: clinicovirologic correlation in a patient with human immunodeficiency virus.

Authors: C Leport; S Puget; J M Pepin; S Levy; C Perronne; F Brun-Vezinet; J L Vildé
Journal: J Infect Dis Date: 1993-11 Impact factor: 5.226

6. Identification of multiple cytomegalovirus strains in homosexual men with acquired immunodeficiency syndrome.

Authors: S A Spector; K K Hirata; T R Newman
Journal: J Infect Dis Date: 1984-12 Impact factor: 5.226

7. Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins.

Authors: G Gerna; M G Revello; E Percivalle; M Zavattoni; M Parea; M Battaglia
Journal: J Clin Microbiol Date: 1990-12 Impact factor: 5.948

8. Rapid antiviral DNA-DNA hybridization assay for human cytomegalovirus.

Authors: W M Dankner; D Scholl; S C Stanat; M Martin; R L Sonke; S A Spector
Journal: J Virol Methods Date: 1990-06 Impact factor: 2.014

9. A ganciclovir-resistant clinical isolate of human cytomegalovirus exhibiting cross-resistance to other DNA polymerase inhibitors.

Authors: W A Tatarowicz; N S Lurain; K D Thompson
Journal: J Infect Dis Date: 1992-10 Impact factor: 5.226

10. Treatment of aggressive cytomegalovirus retinitis with ganciclovir in combination with foscarnet in a child infected with human immunodeficiency virus.

Authors: K M Butler; M D De Smet; R N Husson; B Mueller; K Manjunath; K Montrella; G Lovato; P Jarosinski; R B Nussenblatt; P A Pizzo
Journal: J Pediatr Date: 1992-03 Impact factor: 4.406

13 in total

1. Cytomegalovirus retinitis and the acquired immunodeficiency syndrome--bench to bedside: LXVII Edward Jackson Memorial Lecture.

Authors: Douglas A Jabs
Journal: Am J Ophthalmol Date: 2010-12-18 Impact factor: 5.258

2. Novel real-time monitoring system for human cytomegalovirus-infected cells in vitro that uses a green fluorescent protein-PML-expressing cell line.

Authors: T Ueno; Y Eizuru; H Katano; T Kurata; T Sata; S Irie; K Ogawa-Goto
Journal: Antimicrob Agents Chemother Date: 2006-08 Impact factor: 5.191

3. Detection of Two Drug-Resistance Mutants of the Cytomegalovirus by High-Resolution Melting Analysis.

Authors: Xiao-Fan Chen; Tian-Run Li; Hong Yang; Yong Shao; Jie Zhang; Wei Zhang; Bo Yu; Zhun Wei; Bo Wu; Lin Yu
Journal: J Clin Lab Anal Date: 2015-05-13 Impact factor: 2.352

Review 4. New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.

Authors: I G Sia; R Patel
Journal: Clin Microbiol Rev Date: 2000-01 Impact factor: 26.132

5. Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS.

Authors: F Baldanti; M R Underwood; S C Stanat; K K Biron; S Chou; A Sarasini; E Silini; G Gerna
Journal: J Virol Date: 1996-03 Impact factor: 5.103

9. How evolution of mutations conferring drug resistance affects viral dynamics and clinical outcomes of cytomegalovirus-infected hematopoietic cell transplant recipients.

Authors: Kathryn L Springer; Sunwen Chou; Shaobing Li; Roger H Giller; Ralph Quinones; James E Shira; Adriana Weinberg
Journal: J Clin Microbiol Date: 2005-01 Impact factor: 5.948

Review 10. Antiviral drug resistance of human cytomegalovirus.

Authors: Nell S Lurain; Sunwen Chou
Journal: Clin Microbiol Rev Date: 2010-10 Impact factor: 26.132